MILLENNIUM Trademark

Trademark Overview


On Wednesday, February 14, 2001, a trademark application was filed for MILLENNIUM with the United States Patent and Trademark Office. The USPTO has given the MILLENNIUM trademark a serial number of 76210514. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 12, 2016. This trademark is owned by Millennium Pharmaceuticals, Inc.. The MILLENNIUM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and diagnostic services, namely, diagnosing, [ preventing, ] and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, [ identifying physiological characteristics, establishing individual preventative programs, ] establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields [ ; research consulting services, namely, research, development, validation, testing, data analysis and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields ]
millennium

General Information


Serial Number76210514
Word MarkMILLENNIUM
Filing DateWednesday, February 14, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 12, 2016
Registration Number3042119
Registration DateTuesday, January 10, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 28, 2004

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Column 2, Line 7, after the word development, validation, testing, data analysis and product development services should be inserted.
Goods and ServicesMedical and diagnostic services, namely, diagnosing, [ preventing, ] and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, [ identifying physiological characteristics, establishing individual preventative programs, ] establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields [ ; research consulting services, namely, research, development, validation, testing, data analysis and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields ]

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 12, 2016
Primary Code042
First Use Anywhere DateTuesday, August 23, 2005
First Use In Commerce DateTuesday, August 23, 2005

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, August 12, 2016CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, December 29, 2011NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
Thursday, December 29, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, December 6, 2011POST REGISTRATION ACTION MAILED - SEC. 8
Friday, December 2, 2011TEAS SECTION 8 RECEIVED
Wednesday, June 7, 2006CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, March 3, 2006SEC 7 REQUEST FILED
Friday, April 28, 2006ASSIGNED TO PARALEGAL
Friday, March 3, 2006PAPER RECEIVED
Tuesday, January 10, 2006REGISTERED-PRINCIPAL REGISTER
Monday, November 28, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, November 25, 2005ASSIGNED TO LIE
Friday, November 18, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 18, 2005STATEMENT OF USE PROCESSING COMPLETE
Monday, October 3, 2005USE AMENDMENT FILED
Monday, October 3, 2005PAPER RECEIVED
Thursday, March 24, 2005EXTENSION 1 GRANTED
Tuesday, February 8, 2005EXTENSION 1 FILED
Tuesday, February 8, 2005PAPER RECEIVED
Tuesday, December 21, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2004PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2004NOTICE OF PUBLICATION
Friday, July 30, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 30, 2004ASSIGNED TO LIE
Wednesday, July 28, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 6, 2004AMENDMENT FROM APPLICANT ENTERED
Tuesday, July 6, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 6, 2004PAPER RECEIVED
Tuesday, March 30, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 5, 2004NON-FINAL ACTION MAILED
Tuesday, December 2, 2003CASE FILE IN TICRS
Tuesday, October 15, 2002ASSIGNED TO EXAMINER
Monday, March 25, 2002LETTER OF SUSPENSION MAILED
Monday, December 3, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 4, 2001NON-FINAL ACTION MAILED
Friday, May 25, 2001ASSIGNED TO EXAMINER